Trupanion EV/EBIT TRUP
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2025.
- Today, Oct 23, 2026
- 39.4×
- Peer median
- 23.2×
Trupanion's EV/EBIT is 39.4× as of Oct 23, 2026.
The median for 10 healthcare stocks of a similar size is 23.2×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 39.4× | 28.7× | 78.1× |
| 2025 | 79.5× | 73.4× | 388× |
Against its peers
Companies in Healthcare nearest Trupanion's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| TRUPTrupanion | 39.4× |
| CDRECadre | 23.2× |
| BVSBioventus | 26.2× |
| USPHU S Physical Therapy | 19.8× |
| OMEROmeros | n/m |
| HLFHerbalife | 6.2× |
| OMDAOmada Health | n/m |
| PCRXPacira BioSciences | 7.6× |
| ANABAnaptysbio | n/m |
| STAAStaar Surgical | 57.7× |
| PNTGPennant | 25.1× |
| Peer median | 23.2× |
Where Trupanion ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Trupanion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.